Christopher Ramos, MD
Vascular Surgery · Atlanta, GANPI 1740507425
Payments from drug & device makers
What this record shows
W. L. Gore & Associates, Inc. accounts for 64.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,278 and has fallen 78.0% since, to $281 in 2025. That places this record below the midpoint for vascular surgery clinicians in GA, where the typical reported total is $5,638.
Across 17 payments — averaging $119.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$1K
- Angiodynamics, Inc.$249
- Boston Scientific$186
- Abbott$155
- ETS Wound Care LLC$33
- Lemaitre Vascular, Inc.$33
- plus $58 from 2 others
Across 6 payments — averaging $7645.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Angiodynamics, Inc.$46K
What the payments were for
- Travel & lodging$1,00549%
- Food & beverage$1,03251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 6 | $1,323 |
| Angiodynamics, Inc. | 1 | $249 |
| Boston Scientific | 3 | $186 |
| Abbott | 1 | $155 |
| ETS Wound Care LLC | 2 | $33 |
| Lemaitre Vascular, Inc. | 2 | $33 |
| Imperative Care, Inc | 1 | $30 |
| Silk Road Medical, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,037 in reported general payments places this provider in the 25th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 28 | $19,438 |
| EliquisApixaban | 30 | $17,509 |
| Cilostazol | 36 | $584 |
| Atorvastatin Calcium | 32 | $330 |
| Gabapentin | 52 | $292 |
| ClopidogrelClopidogrel Bisulfate | 25 | $249 |
| Pregabalin | 29 | $217 |
| Rosuvastatin Calcium | 12 | $88 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $38 |
| Oxycodone Hcl | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Atlanta
- Siddharth PatelAtlanta$303K
- Walaya Methodius-RayfordAtlanta$79K
- Andrew UnzeitigAtlanta$46K
- Yazan DuwayriAtlanta$44K
- Anumeha WhisenhuntAtlanta$33K
- James ChangAtlanta$31K
- Chad AlemanAtlanta$21K
- Olamide AlabiAtlanta$19K
- Jorge CorsoAtlanta$18K
- Peter H DoublerAtlanta$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.